Literature DB >> 7398141

A method of determining intrinsic hepatic clearance from the first-pass effect.

L Bass, K Winkler.   

Abstract

1. The relation between systemic hepatic clearance, intrinsic hepatic clearance and hepatic blood fow is considered from the point of view of the sinusoidal perfusion (parallel tube) model of the liver. 2. It is shown how intrinsic hepatic clearance may be calculated, for substrates eliminated in the liver and the kidney only, from data obtained by introducing successively an oral and an intravenous dose (i.e., by using the first-pass effect) with the clinically cumbersome catheterization of the liver vein. 3. The rate of hepatic blood flow is shown to follow from the same data.

Mesh:

Year:  1980        PMID: 7398141     DOI: 10.1111/j.1440-1681.1980.tb00080.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

Review 1.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

2.  Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow.

Authors:  G Molino; A Cavanna; P Avagnina; M Ballaré; M Torchio
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

3.  Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure-pharmacokinetic relationships.

Authors:  N Watari; Y Sugiyama; N Kaneniwa; M Hiura
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

4.  A nonlinear physiologic pharmacokinetic model: I. Steady-state.

Authors:  J G Wagner; G J Szpunar; J J Ferry
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

5.  Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.

Authors:  C Merkel; M Bolognesi; P Angeli; G F Finucci; P Amodio; S Bellon; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.